OptiNose Inc. Watch

from 8-K 12 pages August 13, 2020 Ladies and Gentlemen: Re: Note Purchase Agreement Dated as of September 12, 2019 Among OptiNose US, Inc. (The “Issuer”), the Other Note Parties Party Thereto, Biopharma Credit PLC (As Collateral Agent), Bpcr Limited Partnership (A “Purchaser”) and Biopharma Credit Investments V (Master) LP (A “Purchaser”) Amendment Request Letter

from 8-K 6 pages Date 4/6/2020 Note Amount $ 4446948 Borrower OptiNose US, Inc. Lender Jpmorgan Chase Bank, N.A. 1. Promise to Pay. Borrower Promises to Pay to the Order of Lender the N O T E a Mount, Plus Interest on the Unpaid Principal Balance at the Note Rate, and All Other Amounts Required by This Note. 2. Definitions. 3. Conditions Precedent to Funding of Loan. Before the Funding of the Loan, the Following Conditions Must Be Satisfied: A. Lender Has Approved the Request for the Loan. B. Lender Has Received Approval From Sba to Fund the Loan. 4. Payment Terms